Marcheteau, E.; Farge, T.; Pérès, M.; Labrousse, G.; Tenet, J.; Delmas, S.; Chusseau, M.; Duprez-Paumier, R.; Franchet, C.; Dalenc, F.;
et al. Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer. Cancers 2021, 13, 4059.
https://doi.org/10.3390/cancers13164059
AMA Style
Marcheteau E, Farge T, Pérès M, Labrousse G, Tenet J, Delmas S, Chusseau M, Duprez-Paumier R, Franchet C, Dalenc F,
et al. Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer. Cancers. 2021; 13(16):4059.
https://doi.org/10.3390/cancers13164059
Chicago/Turabian Style
Marcheteau, Elie, Thomas Farge, Michaël Pérès, Guillaume Labrousse, Julie Tenet, Stéphanie Delmas, Maud Chusseau, Raphaëlle Duprez-Paumier, Camille Franchet, Florence Dalenc,
and et al. 2021. "Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer" Cancers 13, no. 16: 4059.
https://doi.org/10.3390/cancers13164059
APA Style
Marcheteau, E., Farge, T., Pérès, M., Labrousse, G., Tenet, J., Delmas, S., Chusseau, M., Duprez-Paumier, R., Franchet, C., Dalenc, F., Imbert, C., Noujarède, J., Colacios, C., Prats, H., Cabon, F., & Ségui, B.
(2021). Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer. Cancers, 13(16), 4059.
https://doi.org/10.3390/cancers13164059
